Sharon Chen is a visionary leader at the intersection of computer science and life sciences, boasting over 25 years of pioneering software development experience. As the Founder and CEO of AlphaLife Sciences, she drives innovation in generative AI-powered clinical development solutions, transforming the way the industry approaches drug development. Previously, Sharon served as the APAC General Manager at Verily Life Sciences, an Alphabet company, where she led groundbreaking initiatives integrating advanced technology with life sciences. Sharon's visionary leadership and innovative spirit continue to profoundly impact AlphaLife Sciences and the broader life sciences sector.

Highly experienced expert FDA-focused strategic regulatory consultant. Former Director Office of New Drugs, CDER, FDA. Over 5 years experience as independent director for publicly traded companies, including successful sale of Provention Bio to Sanofi April 2023. Dr. Jenkins received his M.D. degree from the University of Tennessee at Memphis and completed post-graduate training in internal medicine, pulmonary diseases, and critical care medicine at the Medical College of Virginia/Virginia Commonwealth University in Richmond.

Darren leads the IDAR organization at Johnson & Johnson, overseeing high-quality program delivery and driving continuous improvement and innovation. With a global team of over 2,000 professionals, IDAR manages all Phase I–IV studies across therapeutic areas and regions. Its core functions include Data Management & Central Monitoring, Clinical & Statistical Programming, Regulatory Medical Writing, Clinical Data Standards & Transparency, Business Operations, and Enabling Analytics. Before joining J&J in 2017, Darren spent 16 years at Novartis as VP of Data Sciences & Scientific Operations. He holds a BSc in Chemistry from Brighton University and an MSc in Applied Statistics from Sheffield Hallam University.

Neil Garrett is the Head of Regulatory Medical Writing at Johnson & Johnson Innovative Medicine and has over 25 years' experience in medical writing in the pharmaceutical and CRO industry. Neil has held medical writing leadership positions in a number of organizations and been a lead writer on multiple filing submissions across a range of therapeutic areas. In his current role at J&J, Neil has accountability for the efficient production of high quality clinical and regulatory documents supporting the J&J Innovative Medicine portfolio. Neil is interested in how AI can assist and enhance the authoring process in regulatory medical writing. Neil has a PhD in Pharmacology and is based in the UK.

Eunice Youhanna is a strategic leader and Industry Advisor with deep expertise in pharmaceutical innovation, particularly at the intersection of AI and commercial, medical, regulatory, and R&D functions. She partners with global life sciences organizations to drive transformation across the pharma value chain through emerging technologies. Eunice is known for translating complex scientific and technological trends into actionable strategies that accelerate innovation and deliver measurable impact.